San Antonio, Texas (TX) Commercial Biotechnical Research Companies

Featured companies
Cancer Incite LLC
600 Navarro St # 500
San Antonio TX 78205
(210) 349-0515
Elfamed Inc
1200 Network Boulevard # 300
San Antonio TX 78249
(210) 861-3456
Goliad Scientific LLC
216 Lundblade Lane
San Antonio TX 78213
(210) 844-5415
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Incell Corp LLC
12734 Cimarron Path
San Antonio TX 78249
(210) 877-0100
Nanorelease Technologies LLC
12734 Cimarron Path
San Antonio TX 78249
(210) 877-0100
Oncosa Therapeutics Inc
12500 Network Boulevard # 105
San Antonio TX 78249
(210) 843-3732
Operation Technologies Logistics LLC
4100 Nw Loop 410 # 230
San Antonio TX 78229
(210) 731-0000
Optech Gente LLC
4100 Nw Loop 410 # 230
San Antonio TX 78229
(210) 731-0000
Otc Biotechnologies LLC
4100 Nw Loop 410 # 230
San Antonio TX 78229
(210) 731-0000

Otc Biotechnologies LLC is a privately held company in San Antonio, TX and is a Single Location business.
Phoenix Biotechnology Inc
8626 Tesoro Drive # 801
San Antonio TX 78217
(210) 828-4373
Stembiosys LLC
12500 Network Boulevard # 105
San Antonio TX 78249
(210) 877-9323
Vanessa Arce
10527 Prrin Bitel Road B204
San Antonio TX 78217
(203) 243-2435
Whereorg has 12 results under Commercial Biotechnical Research Companies in San Antonio, TX.

Other locations for category Commercial Biotechnical Research

All states Texas Bexar San Antonio

Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020